Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions
{{output}}
In the present narrative review, we have summarized evidence on the pharmacological treatment of non-alcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD). We start by reviewing the epidemiology of the condition... ...
